BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 15337554)

  • 21. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.
    Kwong DL; Pow EH; Sham JS; McMillan AS; Leung LH; Leung WK; Chua DT; Cheng AC; Wu PM; Au GK
    Cancer; 2004 Oct; 101(7):1584-93. PubMed ID: 15378492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parotid-gland-sparing 3D conformal radiotherapy in patients with bilateral radiotherapy of the head and neck region--results in clinical practice.
    Hey J; Setz J; Gerlach R; Janich M; Sehlleier S; Schaller HG; Gernhardt CR; Kuhnt T
    Oral Oncol; 2009 Feb; 45(2):e11-7. PubMed ID: 18621572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bath and shower effects in the rat parotid gland explain increased relative risk of parotid gland dysfunction after intensity-modulated radiotherapy.
    van Luijk P; Faber H; Schippers JM; Brandenburg S; Langendijk JA; Meertens H; Coppes RP
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1002-5. PubMed ID: 19545785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS; Weber RS; Garden AS
    J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Presentation of a 3D conformal radiotherapy technique for head-and-neck tumors resulting in substantial protection of the parotid glands].
    Kuhnt T; Janich M; Götz U; Gerlach R; Chiricuta IC; Hänsgen G
    Strahlenther Onkol; 2006 Jun; 182(6):325-30. PubMed ID: 16703287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships.
    Roesink JM; Moerland MA; Hoekstra A; Van Rijk PP; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1451-60. PubMed ID: 15050323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sparing of contralateral major salivary glands has a significant effect on oral health in patients treated with radical radiotherapy of head and neck tumors.
    Beer KT; Zehnder D; Lussi A; Greiner RH
    Strahlenther Onkol; 2002 Dec; 178(12):722-6. PubMed ID: 12491061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
    Saarilahti K; Kouri M; Collan J; Kangasmäki A; Atula T; Joensuu H; Tenhunen M
    Radiother Oncol; 2006 Mar; 78(3):270-5. PubMed ID: 16564589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
    Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The relationship between the parotid glands function and the dose-volume effect in nasopharyngeal carcinoma patients with intensity-modulated radiation therapy].
    Sun XN; Chen AZ; Xie CY; Jin XC; Wu SX; Zhang P; Li HB
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2289-92. PubMed ID: 17064579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT.
    Hunt MA; Jackson A; Narayana A; Lee N
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):296-304. PubMed ID: 16904529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.